Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 June 2007, Vol. 109, No. 12, pp. 5215-5222.
Prepublished online as a Blood First Edition Paper on February 27, 2007; DOI 10.1182/blood-2006-10-055350.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-10-055350v1
109/12/5215    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, L.
Right arrow Articles by Verdier, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, L.
Right arrow Articles by Verdier, F.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Cell Cycle
Right arrow Signal Transduction
Right arrow Gene Expression
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

HEMATOPOIESIS

ß-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation

Laure Meyer1,3,5, Bénédicte Deau1,3,5, Hana Forejtníková1,3,5, Dominique Duménil1,3,5, Florence Margottin-Goguet2,5, Catherine Lacombe1,3,5, Patrick Mayeux1,3,5, and Frédérique Verdier1,3,5

1 Institut Cochin, Département d'Hématologie, Paris, France; 2 Institut Cochin, Département des Maladies Infectieuses, Paris, France; 3 Institut National de la Santé et de la Recherche, Médicale (INSERM), U567, Paris, France; 4 Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 8104, Paris, France; 5 Université Paris Descartes, Faculté de Médecine René Descartes, UMR-S 8104, Paris, France; 6 Laboratoire d'Hématologie, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France

Control of intensity and duration of erythropoietin (Epo) signaling is necessary to tightly regulate red blood cell production. We have recently shown that the ubiquitin/proteasome system plays a major role in the control of Epo-R signaling. Indeed, after Epo stimulation, Epo-R is ubiquitinated and its intracellular part is degraded by the proteasome, preventing further signal transduction. The remaining part of the receptor and associated Epo are internalized and degraded by the lysosomes. We show that ß-Trcp is responsible for Epo-R ubiquitination and degradation. After Epo stimulation, ß-Trcp binds to the Epo-R. This binding, like Epo-R ubiquitination, requires Jak2 activation. The Epo-R contains a typical DSG binding sequence for ß-Trcp that is highly conserved among species. Interestingly, this sequence is located in a region of the Epo-R that is deleted in patients with familial polycythemia. Mutation of the serine residue of this motif to alanine (Epo-RS462A) abolished ß-Trcp binding, Epo-R ubiquitination, and degradation. Epo-RS462A activation was prolonged and BaF3 cells expressing this receptor are hypersensitive to Epo, suggesting that part of the hypersensitivity to Epo in familial polycythemia could be the result of the lack of ß-Trcp recruitment to the Epo-R.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
Y. Jia, R. Warin, X. Yu, R. Epstein, and C. T. Noguchi
Erythropoietin signaling promotes transplanted progenitor cell survival
FASEB J, September 1, 2009; 23(9): 3089 - 3099.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Sulahian, O. Cleaver, and L. J.-s. Huang
Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia
Blood, May 21, 2009; 113(21): 5287 - 5297.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. M. Piazza, J.-C. Lu, K. C. Carver, and L. A. Schuler
Src Family Kinases Accelerate Prolactin Receptor Internalization, Modulating Trafficking and Signaling in Breast Cancer Cells
Mol. Endocrinol., February 1, 2009; 23(2): 202 - 212.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Varghese, H. Barriere, C. J. Carbone, A. Banerjee, G. Swaminathan, A. Plotnikov, P. Xu, J. Peng, V. Goffin, G. L. Lukacs, et al.
Polyubiquitination of Prolactin Receptor Stimulates Its Internalization, Postinternalization Sorting, and Degradation via the Lysosomal Pathway
Mol. Cell. Biol., September 1, 2008; 28(17): 5275 - 5287.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Fang, M. Menon, D. Zhang, B. Torbett, L. Oxburgh, M. Tschan, E. Houde, and D. M. Wojchowski
Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2
Blood, August 1, 2008; 112(3): 886 - 890.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
F. Mannello and G. A. M. Tonti
Erythropoietin and Its Receptor in Breast Cancer: Putting Together the Pieces of the Puzzle
Oncologist, July 1, 2008; 13(7): 761 - 768.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
G. Swaminathan, B. Varghese, C. Thangavel, C. J Carbone, A. Plotnikov, K G S. Kumar, E. M Jablonski, C. V Clevenger, V. Goffin, L. Deng, et al.
Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2
J. Endocrinol., February 1, 2008; 196(2): R1 - R7.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020